🇺🇸 FDA
Patent

US 9181306

Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 9181306 (Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/5258, A61K2039/545